The role of radiotracer imaging in Parkinson disease.
Zweig
Richard M
RM
Lilien
David L
DL
Tainter
Kerrie
K
Patterson
James
J
D001921:Brain / Q000000981:diagnostic imaging / Q000378:metabolism / Q000503:physiopathology; D004295:Dihydroxyphenylalanine / Q000031:analogs & derivatives; D018450:Disease Progression; D004298:Dopamine / Q000378:metabolism; D010300:Parkinson Disease / Q000000981:diagnostic imaging* / Q000191:economics* / Q000503:physiopathology; D018579:Patient Selection; D049268:Positron-Emission Tomography / Q000191:economics* / Q000379:methods / Q000639:trends; D011237:Predictive Value of Tests; D015899:Tomography, Emission-Computed, Single-Photon / Q000191:economics* / Q000379:methods / Q000639:trends
C043437:fluorodopa F 18; D004295:Dihydroxyphenylalanine; D004298:Dopamine